ROSENBERGER BRIAN (VP, Commercial) sold 3.8% of their position (4.29K shares) of ZYNERBA PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $4.7K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 7/20/2022ACC: 0001062993-22-016557
Officer· VP, Commercial
Since Jan 2019
+10.51K
Net shares
Net buyer
$4.7K
Total sold
1
Open market trades
0B · 1S
2
Total transactions
14.80K acquired · 4.29K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+14.80K
Price / share
—
Trade value
—
% of position
15.3%
7/18/2022
97K→111.80K
Common Stock
Direct
Shares
−4.29K
Price / share
$1.10
Trade value
$4.72K
% of position
3.8%
7/19/2022
111.80K→107.51K
Total
Net shares
+10.51K
Net value
-$4.72K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/18/2022 | A · Award | +14.80K | — | — | 15.3% | 97K | 111.80K |
| Common Stock Direct | 7/19/2022 | S · Sale | −4.29K | $1.10 | $4.72K | 3.8% | 111.80K | 107.51K |
| Total | +10.51K | -$4.72K | ||||||
Derivative Transactions0
No derivative transactions reported